Breaking News

Over a quarter ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Psychemedics increases dividend to 7c per share, strategic review continues » 17:28
05/10/22
05/10
17:28
05/10/22
17:28
PMD

Psychemedics

$6.11 /

+0.01 (+0.16%)

Raymond C. Kubacki,…

Raymond C. Kubacki, Chairman and Chief Executive Officer, of Psychemedics stated: "We are off to a strong start in the first quarter of 2022. Total revenues increased 14%; but more importantly, domestic revenues increased 17%. The main drivers in this improved revenue performance were continued growth in key market segments including Oil and Gas, Transportation and Manufacturing. International revenues, primarily Brazil, declined 42% but on a much smaller base. Brazil volumes continue to be unpredictable, and our focus remains on our domestic business." Based on the strengthening fundamentals and revenue growth, the Board made the decision to initiate an increase in return to shareholders in the form of an increased cash dividend of 7c per share of outstanding common stock. Our Board of Directors shares our confidence in the future of Psychemedics and remains committed to rewarding shareholders and sharing the financial success of the Company with them as we grow. We will continue to evaluate the dividend as we move forward. Throughout 2021 and also 2022, we have stated that we are exploring ways to further enhance shareholder value through a comprehensive review of strategic alternatives. We continue to explore such opportunities. There can be no assurances that the strategic alternatives review process will result in a transaction or other strategic change or outcome. The management team and Board of Directors are committed to continuing to evaluate all avenues for enhancing shareholder value."

ShowHide Related Items >><<
PMD Psychemedics
$6.11 /

+0.01 (+0.16%)

Hot Stocks
Psychemedics appoints Reynolds to board of directors, Connick to retire » 08:36
03/22/22
03/22
08:36
03/22/22
08:36
PMD

Psychemedics

$7.30 /

-0.12 (-1.62%)

Psychemedics appoints…

Psychemedics appoints Andrew Reynolds to the Psychemedics Board of Directors effective April 4th, 2022. Mr. Reynolds will also serve as a member of the Audit, Compensation, and Nominating and Governance Committees. Currently, Drew serves as an independent director for AddSecure, Idle Smart, and Linxup. Drew is also on the advisory board of Locomation. The Company is also announcing that Harry Connick plans to retire from the Psychemedics Board of Directors effective April 4th, 2022. Connick has served as a board director for over 18 years and has been a member of the Audit, Compensation, and Nominating and Governance Committees.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.